College of Medicine
Developing a new generation of intra-operative neuro-monitoring devices and a neurochemical diagnostic probe to better serve patients with epilepsy and traumatic brain injury.
Bluegrass Vascular Technologies
Founded in 2011 and based in Lexington, Ky., BVT is a medical technology company dedicated to developing and commercializing life-saving devices and methods that address shortcomings in vascular access procedures. BVT's flagship product is the Surfacer™ Inside-Out Access Catheter System, a proprietary system that allows physicians to perform a novel “inside-out” approach to gain venous access.
2260 Carolina Lane, Lexington, KY 40513-1827 | 859.323.6494
Cardiojustable develops specialized cardiovascular devices for pediatric cardiac surgery. Cardiojustable is currently developing the first-ever adjustable vascular graft for control of pulmonary blood flow for infants with single ventricle physiology. Based on the research of William Douglas, surgery.
Manufactures proteins and enzymes for biomedical research, and offers custom protein purification and custom DNA constructions using advanced biotechnologies. Based on the research of Zhigang Wang, toxicology.
Eric Hauck | 866.260.6930 | www.equinext.net
Equinext formed a partnership with Hagyard Equine Medical Institute to bring a medical device to the equine market to treat tendon and ligament injuries and Wobbler's Syndrome in horses and other animals. Equinext will use its chemically-made injectable reagent device on these lower leg strains and sprains, which are very common in all types of performance horses and have a high rate of reoccurrence. Equinext is located at UK Coldstream Research Campus.
HiberNetics is identifying the clinical potential of opioid peptides, referred to as deltorphins, in treating stroke. Current research indicates that the use of these peptides within minutes to hours after a stroke can provide a dramatic new approach to neuroprotection. HiberNetics has demonstrated that these deltorphins can also reduce cerebral and myocardial ischemic injury and enhance survival following severe hemorrhage. Based on research by Peter Oeltgen, medicine.
Guangxiang Luo | 859.257.5577
IP Pharmaceuticals is developing stable cell lines that produce HCV (hepatitis C virus). Based on the research of Guangxiang Luo, MD, MPH, in the Department of Microbiology, Immunology and Molecular Genetics.
Robert Mudd | 859.368.8838 | www.labdx.biz
LabDX is a clinical reference laboratory devoted to the highest level of patient care in the delivery of diagnostic information. Their experienced team, state-of-the-art facility and interfaced laboratory information system allow the company to achieve accurate and expedient delivery of patient results.
Professors Chunming Liu and David Watt formed Liu-Watt in 2011 to develop new chemical agents based on naturally occurring compounds for the treatment of colon and liver cancers. Liu and Watt are in the Department of Molecular & Cellular Biochemistry.
Nano-Mite, based on the research of Patrick G. Sullivan, with UK's Spinal Cord & Brain Injury Research Center (SCoBIRC) and the Department of Anatomy & Neurobiology, is focused on controlling obesity — in both humans and pets — using nanotechnology. Nano-Mite has developed, and is currently testing, a nanoscale medical device that serves as mitochondrial uncouplers to increase metabolism and result in weight loss.
Eric Hauck | 866.260.6930 | www.orthopeutics.com
Orthopeutics L.P./Intralink Spine was founded in May 2004 to further develop and commercialize revolutionary nonsurgical solutions for common orthopaedic problems. Orthopeutic's current focus involves a path-breaking, nonsurgical treatment to repair the intervertebral disc, dramatically reducing disc degradation and spinal joint instability.
John Williams | 859.323.5049
OsteoRegeneron is built around three patents obtained for a novel bone chemokine that stimulates osteoblast differentiation. This product will represent the first non-hormonal anabolic agent to increase bone density.
Develops microsensor technologies to measure neurochemicals, including dopamine, norepinephrine, serotonin, nitric oxide, and glutamate. Microsensor development and fabrication, Windows-based software for data recording and analysis, instrumentation development, and microelectronic interfaces. Based on the research of Greg Gerhardt, medicine.
1748 Brook Park Drive Lexington, KY 40515-1309 | 859.272.5082
Develops optical imaging equipment for use in minimally invasive surgery, including a 3-D imaging system to achieve real time improvements in surgical vision. Based on the work of Michael F. Shaw, Center for Minimally Invasive Surgery.
Ed Hall | 859.425.1043
Stallion Therapeutics is a Lexington based startup pharmaceutical company interested in developing neuroprotective and neurorestorative compounds for traumatic brain injury, spinal cord injury and other acute neurological disorders. The founder of Stallion is Edward D. Hall, director of the University of Kentucky Spinal Cord & Brain Injury Research Center (SCoBIRC) and SCoBIRC Endowed Professor of Anatomy & Neurobiology, Neurology and Neurosurgery.
Therix is a privately funded UK medical technology incubator company that pairs an experienced business development team with clinicians to develop their medical device and diagnostic concepts, including prototype development, regulatory assessment, financial modeling and intellectual property protection. Therix was co-founded by UK cardiologist Dr. John Gurley in 2009.
Guangxiang Luo | 859.257.5577
ViroTac is developing antibodies and viral enzymes. Based on the research of Guangxiang Luo, MD, MPH, in the Department of Microbiology, Immunology and Molecular Genetics.
WTT, founded in 1988, was based on the research of founders David Watt (College of Medicine, cellular and molecular biochemistry), Dan Tai (College of Pharmacy), and Tom Tobin (College of Agriculture, Gluck Equine Research Center). WTT developed enzyme-linked immunosorbent assay (ELISA ) tests for drugs of abuse in race horses and dogs. They had developed 29 diagnostic tests before the company was sold to the international food and animal safety company, Neogen in 1991. Neogen’s Animal Safety Division is based in Lexington, Ky.
W-Z Biotech specializes in the development of novel medical devices for cardiopulmonary surgery and hyperthermia delivery systems for lung cancer therapy. The company was founded in 2009 by Dr. Jay Zwischenberger, surgery, and Dr. Dongfang Wang, cardiothoracic surgery.